Published in Drug Des Devel Ther on September 21, 2017
Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med (2008) 18.27
Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem (1986) 10.00
Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis. Cytokine Growth Factor Rev (2005) 2.69
Snail is required for TGFbeta-induced endothelial-mesenchymal transition of embryonic stem cell-derived endothelial cells. J Cell Sci (2008) 2.09
Interference with TGF-beta signaling by Smad3-knockout in mice limits diabetic glomerulosclerosis without affecting albuminuria. Am J Physiol Renal Physiol (2007) 1.38
Renal protection in diabetes: role of glycemic control. J Am Soc Nephrol (2006) 1.30
Recent insights into diabetic renal injury from the db/db mouse model of type 2 diabetic nephropathy. Am J Physiol Renal Physiol (2010) 1.27
Epidemiology of diabetic nephropathy. Contrib Nephrol (2011) 1.18
Kidney-targeting Smad7 gene transfer inhibits renal TGF-β/MAD homologue (SMAD) and nuclear factor κB (NF-κB) signalling pathways, and improves diabetic nephropathy in mice. Diabetologia (2011) 1.06
Review of Herbal Traditional Chinese Medicine for the Treatment of Diabetic Nephropathy. J Diabetes Res (2015) 0.95
Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy: Fact or Fiction? Cells (2015) 0.94
Echinacoside rescues the SHSY5Y neuronal cells from TNFalpha-induced apoptosis. Eur J Pharmacol (2004) 0.90
Long-term study of normal kidneys transplanted into patients with type I diabetes. Diabetes (1989) 0.87
TGF-β: the connecting link between nephropathy and fibrosis. Immunopharmacol Immunotoxicol (2016) 0.84
Diabetic Nephropathy: Emerging Biomarkers for Risk Assessment. Diabetes (2015) 0.84
Peripheral osmotic stimulation inhibits the brain's innate immune response to microdialysis of acidic perfusion fluid adjacent to supraoptic nucleus. Am J Physiol Regul Integr Comp Physiol (2009) 0.82
BAMBI elimination enhances alternative TGF-β signaling and glomerular dysfunction in diabetic mice. Diabetes (2015) 0.82
Metabolism of echinacoside, a good antioxidant, in rats: isolation and identification of its biliary metabolites. Drug Metab Dispos (2008) 0.81
A pathological scoring system to predict renal outcome in diabetic nephropathy. Am J Nephrol (2015) 0.81
Diabetes and Complications: Cellular Signaling Pathways, Current Understanding and Targeted Therapies. Curr Drug Targets (2016) 0.81
Management of diabetic kidney disease: Recent advances. Indian J Endocrinol Metab (2013) 0.81
Prediction of cardiovascular events, diabetic nephropathy, and mortality by albumin concentration in a spot urine sample in patients with type 2 diabetes. J Diabetes Complications (2012) 0.81
Phenylethanol Glycosides from Cistanche tubulosa Suppress Hepatic Stellate Cell Activation and Block the Conduction of Signaling Pathways in TGF-β₁/smad as Potential Anti-Hepatic Fibrosis Agents. Molecules (2016) 0.81
[Analysis of phenylethanoid glycosides of Herba cistanchis by RP-HPLC]. Yao Xue Xue Bao (1997) 0.80
SGLT2 Protein Expression Is Increased in Human Diabetic Nephropathy: SGLT2 PROTEIN INHIBITION DECREASES RENAL LIPID ACCUMULATION, INFLAMMATION, AND THE DEVELOPMENT OF NEPHROPATHY IN DIABETIC MICE. J Biol Chem (2017) 0.79
Prognostic indicators in patients presenting with the nephrotic syndrome. Kidney Int (1988) 0.79
Curcumin Ameliorates Diabetic Nephropathy by Suppressing NLRP3 Inflammasome Signaling. Biomed Res Int (2017) 0.77
Effect of berberine on the renal tubular epithelial-to-mesenchymal transition by inhibition of the Notch/snail pathway in diabetic nephropathy model KKAy mice. Drug Des Devel Ther (2017) 0.77
Rodent models of diabetic nephropathy: their utility and limitations. Int J Nephrol Renovasc Dis (2016) 0.75
Transforming growth factor β1 and diabetic nephropathy. Am J Physiol Renal Physiol (2015) 0.75
Liuwei Dihuang pill treats diabetic nephropathy in rats by inhibiting of TGF-β/SMADS, MAPK, and NF-kB and upregulating expression of cytoglobin in renal tissues. Medicine (Baltimore) (2017) 0.75